M&A

J&J’s Raised Offer for Actelion Said North of $250 a Share
Bloomberg
Sat, 12/3/16 - 12:06 am
JNJ
M&A
Actelion
Valeant: Don't WrIte Off Salix's Sale Potential
Seeking Alpha
Thu, 12/1/16 - 04:27 pm
Valeant Pharmaceuticals
hirings
Salix
Takeda
M&A
What's Pfizer's Excuse for Not Buying Exelixis?
Motley Fool
Wed, 11/30/16 - 09:46 pm
Pfizer
Exelixis
M&A
Cabometyx
kidney cancer
Sutent
Johnson & Johnson Throws Caution to the Wind With a Large Bid for Actelion
Motley Fool
Wed, 11/30/16 - 10:07 am
JNJ
Actelion
M&A
J&J Raises Takeover Offer for Europe's Largest Biotech Firm Actelion
Bloomberg
Wed, 11/30/16 - 10:06 am
JNJ
Actelion
M&A
Actelion Shares Fall Sharply on Report It Is Resisting $17 Billion J&J Takeover
TheStreet.com
Tue, 11/29/16 - 09:56 am
Actelion
JNJ
M&A
J&J confirms it is in talks to buy Swiss biotech Actelion
Endpoints
Sun, 11/27/16 - 03:57 pm
JNJ
Actelion
M&A
[video]J&J Said to Make Takeover Approach for Actelion
Bloomberg
Fri, 11/25/16 - 09:33 am
JNJ
Actelion
M&A
What Happened in Biotech in 2016?
Motley Fool
Tue, 11/22/16 - 09:57 pm
biotech
M&A
biosimilars
IPOs
Editas Medicine
CRISPR Therapeutics
Pfizer
Medivation
Celgene
Juno Therapeutics
Sarepta Therapeutics
Boston Scientific closes $210m EndoChoice buy
Mass Device
Tue, 11/22/16 - 11:29 am
Boston Scientific
devices
EndoChoice
M&A
Novartis buys sickle cell player Selexys in $665M deal
Fierce Biotech
Mon, 11/21/16 - 11:34 am
Novartis
Selexys
M&A
sickle cell disease
Sorry, Aetna And Anthem: Trump Won't Stop Antitrust Scrutiny Of Healthcare
Forbes
Fri, 11/18/16 - 10:04 am
Aetna
Anthem
M&A
antitrust
Donald Trump
Should Gilead Sciences Purchase Incyte?
Seeking Alpha
Fri, 11/18/16 - 10:02 am
Gilead Sciences
Incyte
M&A
Abbott Laboratories: As Acquisition Uncertainty Lingers, CEO Makes A Multi-Million Dollar Purchase
Seeking Alpha
Thu, 11/17/16 - 09:46 am
Abbott Labs
Pharma CEOs
St. Jude Medical
M&A
3 Potential Acquisition Targets for Gilead Sciences, Inc.
Motley Fool
Wed, 11/16/16 - 10:00 pm
Gilead Sciences
Kite Pharma
Tesaro
Intercept Pharma
M&A
Novartis May Buy Generics Maker Amneal for $8B
Investopedia
Wed, 11/16/16 - 09:48 am
Novartis
Amneal
generics
eye health
M&A
Novartis mulls sale for underperforming Alcon eye division
Mass Device
Mon, 11/14/16 - 10:50 pm
Novartis
Alcon
devices
M&A
Go for It, Pfizer -- Sell Your Consumer Healthcare Business
Motley Fool
Mon, 11/14/16 - 10:46 pm
Pfizer
consumer healthcare
M&A
Bristol-Myers pens $100M NASH, fibrosis drug deal with Japan’s Nitto
Fierce Biotech
Fri, 11/11/16 - 09:52 am
Bristol-Myers Squibb
M&A
NASH
fibrosis
Japan
Nitto
Trump presidency could prove a salve for pharma merger deals
Yahoo/Reuters
Fri, 11/11/16 - 09:45 am
Donald Trump
M&A
Pfizer
Valeant Pharmaceuticals
biotech
Sarepta Therapeutics
Tesaro

Pages